Oral candidiasis
is a very common oral condition among susceptible
individuals, with the main causative organism being the fungus
Candida albicans
. Current drug delivery systems to
the oral mucosa are often ineffective because of short drug/tissue
contact times as well as increased prevalence of drug-resistant
Candida
strains. We evaluated the potency of saturated
fatty acids as antifungal agents and investigated their delivery by
novel electrospun mucoadhesive oral patches using agar disk diffusion
and biofilm assays. Octanoic (C8) and nonanoic (C9) acids were the
most effective at inhibiting
C. albicans
growth on disk diffusion assays, both in solution or when released
from polycaprolactone (PCL) or polyvinylpyrrolidone/RS100 (PVP/RS100)
electrospun patches. In contrast, dodecanoic acid (C12) displayed
the most potent antifungal activity against pre-existing
C. albicans
biofilms in solution or when released
by PCL or PVP/RS100 patches. Both free and patch-released saturated
fatty acids displayed a significant toxicity to wild-type and azole-resistant
strains of
C. albicans
. These data
not only provide evidence that certain saturated fatty acids have
the potential to be used as antifungal agents but also demonstrate
that this therapy could be delivered directly to
Candida
-infected sites using electrospun mucoadhesive patches, demonstrating
a potential new therapeutic approach to treat oral thrush.